Platinum coordination compounds in cancer chemotherapy

Critical Reviews in Oncology/Hematology

Volumn 53, Issue 1, 2005, Pages 1-2

  Muggia, Franco ^a   Farrell, Nicholas ^b  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CISPLATIN; OXALIPLATIN; PLATINUM DERIVATIVE;

ANTINEOPLASTIC ACTIVITY; CANCER CHEMOTHERAPY; CONFERENCE PAPER; DNA DRUG COMPLEX;

EID: 10644281194     PISSN: 10408428     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.critrevonc.2004.11.007     Document Type: Conference Paper

References (10)

1. Chaney SG, Campbell SL, Bassett E, Wu Y. Recognition and processing of cisplatin- and oxaliplatin-DNA adducts. 2005;53:3-11.
2. Safaei R, Howell SB. Copper transporters regulate the cellular pharmacology and sensitivity to Pt drugs. 2005;53:13-23.
3. Fojo T, Farrell N, Ortuzar W. et al. Identification of non-cross resistant platinum compounds with novel cytotoxicity profiles using the NCI anticancer drug screen and clustered image map visualizations. 2005;53:25-34.
4. F.M. Muggia Future of cancer chemotherapy with cisplatin Semin Oncol. 16 suppl. 6 1989 123 128
5. F.M. Muggia Overview of carboplatin: replacing, complementing, and extending the therapeutic horizons of cisplatin Semin Oncol. 16 suppl. 6 1989 1 7
6. de Gramont A, Figer A, Seymour M. et al. Leucovorin and fluorouracil with or without oxaliplatin as first line treatment in advanced colorectal cancer. J Clin Oncol. 2000;18:2938-47.
7. M. Markman, and W. Hoskins Responses to salvage chemotherapy in ovarian cancer: a critical need for precise definitions of the treated population J Clin Oncol. 10 4 1992 513 514
8. Spriggs D. Duration of therapy for ovarian cancer: How long is enough? Cancer Investigation. 2004;1(Suppl):44.
9. Berners-Price S, Farrell N. The ninth international symposium on platinum compounds in cancer chemotherapy (Editorial). J Inorganic Biochem. 2004;98(10):V.
10. Rosenberg B. Cisplatin: It's history and possible mechanisms of action. In: Cisplatin Current Status and New Developments. AW Prestayko, ST Crooke, and SK Carter. Academic Press, Inc., New York pp. 9-20, 1980.